# Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study A

> **NCT03519347** · NA · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 19 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **OTHER:** Potassium Removal Maximization
- **OTHER:** Potassium Gradient Minimization
- **OTHER:** Alkalosis Avoidance
- **OTHER:** Acidosis avoidance
- **DIAGNOSTIC_TEST:** Point of Care Testing
- **DEVICE:** Cardiac Monitor

## Key facts

- **NCT ID:** NCT03519347
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-30
- **Primary completion:** 2022-07-12
- **Final completion:** 2022-10-14
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-08-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03519347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03519347, "Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study A". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03519347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*